Servicios Personalizados
Revista
Articulo
Indicadores
Citado por SciELO
Links relacionados
Similares en
SciELO
Compartir
Revista de salud publica del Paraguay
versión impresa ISSN 2224-6193versión On-line ISSN 2307-3349
Resumen
RODRIGUEZ, María Galiana et al. Clinical practice guideline for the treatment and follow-up of individuals with differentiated thyroid cancer. Part II: treatment, follow-up and management of radioiodine-refractory DTC. Rev. salud publica Parag. [online]. 2025, vol.15, n.2, pp.42-53. ISSN 2224-6193. https://doi.org/10.18004/rspp.2025.ago.07.
Introduction:
Differentiated thyroid cancer (DTC) represents most thyroid malignancies and requires recommendations that integrate risk stratification and active surveillance for low risk microcarcinomas. This second installment addresses previously defined key questions: indications and frequency of active surveillance; treatment of thyroid nodules suspected of being cancerous; follow-up according to dynamic risk; and management of iodine-refractory DTC.
Objective:
To generate evidence-based recommendations on the treatment and follow-up of adults with differentiated thyroid cancer.
Methodology:
Development of clinical practice guideline through a systematic literature review (SLR) and expert consensus. The group defined the scope and 4 questions of interest. Each question was addressed through updates to existing guidelines, SLRs with and without meta-analyses, clinical trials, and observational studies (Medline/PubMed and Embase; last 10 years; English/Spanish). The selected documents were peer-reviewed by clinicians and methodologists based on consistency in scope, methodological transparency, and formulation/grading of recommendations.
Results:
51 recommendations were included, grouped according to four questions of clinical interest: 10 define eligibility criteria for active surveillance, ultrasound schedule and frequency, and data recording; 20 establish indications for treatment of suspicious thyroid nodules, differentiating lobectomy from total thyroidectomy, as well as radioiodine therapy and minimally invasive therapies, promoting multidisciplinary evaluation; 14 address follow-up according to dynamic risk, defining response categories (excellent, biochemical, or structural incomplete and indeterminate) and guidelines for ultrasound and thyroglobulin measurement with TSH adjustment; finally, 7 focus on the management of iodine-refractory thyroid cancer, including individualized doses of I131, minimally invasive techniques for oligometastases, and combined use of radiotherapy for symptomatic control.
Conclusion:
All recommendations were graded as “strong” or “conditional” based on the quality of evidence, the risk-benefit balance, and feasibility in the Paraguayan context.
Palabras clave : papillary thyroid cancer/treatment; thyroid neoplasms; Radioiodine-Refractory Thyroid Cancer; thyroid nodule.











